惠生工程(02236.HK)簽訂卡塔爾油田硫磺設施合同
惠生工程(02236.HK)公布,由Tecnicas Reunidas S.A.與公司附屬惠生工程(中國)成立的聯合體,近期與QatarEnergy就卡塔爾北部油田硫磺設施擴建EPC-4項目訂立設計、採購、施工及調試合同。
項目涉及建造新的硫磺處理、儲存和裝載設施,以處理和出口卡塔爾國拉斯拉凡工業城正在進行的液化天然氣工廠擴建中產生的硫磺。新硫磺廠將平均每天處理5,000噸熔融硫磺。EPC-4項目預計將在48個月內完成。
惠生工程(中國)和Tecnicas Reunidas S.A.將負責提供EPC -4項目設施中的詳細設計、採購、施工及調試工作及服務。惠生工程(中國)將收取該合同總額的30%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.